PROPHYLACTIC EFFICACY OF WASHED CORD BLOOD AGAINST ANAPHYLAXIS ASSOCIATED WITH CORD BLOOD TRANSPLANTATION: A CASE REPORT
-
- Mizumura Shinya
- Department of Transfusion Medicine, Toranomon Hospital
-
- Takahashi Rina
- Department of Transfusion Medicine, Toranomon Hospital
-
- Seki Noriko
- Department of Transfusion Medicine, Toranomon Hospital
-
- Sakurai Rie
- Department of Transfusion Medicine, Toranomon Hospital
-
- Yoshino Tatsuhiro
- Department of Transfusion Medicine, Toranomon Hospital
-
- Yoshii Shinji
- Department of Transfusion Medicine, Toranomon Hospital
-
- Kaihori Izumi
- Department of Transfusion Medicine, Toranomon Hospital
-
- Fukawa Masanori
- Department of Transfusion Medicine, Toranomon Hospital
-
- Taya Yuki
- Department of Hematology, Toranomon Hospital
-
- Takahashi Atsuko
- Department of Cell Processing and Transfusion, The Institute of Medical Science, The University of Tokyo
-
- Nagamura-Inoue Tokiko
- Department of Cell Processing and Transfusion, The Institute of Medical Science, The University of Tokyo
-
- Makino Shigeyoshi
- Japanese Red Cross Tokyo Metropolitan Blood Center
-
- Asano-Mori Yuki
- Department of Transfusion Medicine, Toranomon Hospital
Bibliographic Information
- Other Title
-
- 臍帯血移植時のアナフィラキシー対策として洗浄臍帯血が有効であった1例
Abstract
<p>We report the successful prevention of recurrent anaphylaxis with washed cord blood (CB) at second cord blood transplantation (CBT) in a patient who experienced severe anaphylactic events during infusion at the first CBT.</p><p>A Japanese woman in her 30s diagnosed with acute myelogenous leukemia (AML) received the first CBT (nucleated cell count (NCC) 1.72×107/kg). When the approximate 80% compartment of the CB unit was infused, anaphylaxis with dyspnea, hypoxia and hypotension occurred. The infusion was immediately stopped and she was treated with intramuscular injection of epinephrine. Although the remaining 20% portion was not infused, engraftment was achieved at day 25 after transplantation. At 18 months after the first CBT, retransplantation was planned for AML relapse using washed CB to prevent recurrence of anaphylaxis. After one CB unit (NCC 3.20×107/kg) was thawed in a 37°C water bath, it was slowly diluted with a solution containing albumin and dextran (ALB/D) and centrifuged while cooling. The supernatant was removed, and the ALB/D solution was added to a final volume of 50ml. The washed CB was infused into the patient as soon as possible. No anaphylactic reaction was observed, and CB cells were successfully engrafted at day 13 after the second CBT.</p>
Journal
-
- Japanese Journal of Transfusion and Cell Therapy
-
Japanese Journal of Transfusion and Cell Therapy 69 (5), 610-614, 2023-10-05
The Japan Society of Transfusion Medicine and Cell Therapy
- Tweet
Details 詳細情報について
-
- CRID
- 1390016427484510208
-
- ISSN
- 18830625
- 18813011
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
-
- Abstract License Flag
- Disallowed